JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,497 | -91.6% | 15,404 | -89.4% | 0.00% | -100.0% |
| Q3 2022 | $339,000 | -11.3% | 144,885 | +14.9% | 0.00% | 0.0% |
| Q2 2022 | $382,000 | -67.1% | 126,073 | -26.3% | 0.00% | -66.7% |
| Q1 2022 | $1,162,000 | -20.4% | 171,124 | -2.1% | 0.01% | -14.3% |
| Q4 2021 | $1,459,000 | +62.5% | 174,738 | +44.5% | 0.01% | +40.0% |
| Q3 2021 | $898,000 | +81.8% | 120,898 | +66.5% | 0.01% | +66.7% |
| Q2 2021 | $494,000 | -43.5% | 72,596 | -14.8% | 0.00% | -40.0% |
| Q1 2021 | $875,000 | +31.6% | 85,195 | -10.3% | 0.01% | +25.0% |
| Q4 2020 | $665,000 | -18.8% | 94,929 | -5.4% | 0.00% | -20.0% |
| Q3 2020 | $819,000 | -33.9% | 100,386 | -44.1% | 0.01% | -44.4% |
| Q2 2020 | $1,239,000 | +41.8% | 179,564 | -2.5% | 0.01% | +12.5% |
| Q1 2020 | $874,000 | -46.3% | 184,088 | -1.3% | 0.01% | -27.3% |
| Q4 2019 | $1,628,000 | +159.6% | 186,488 | -0.9% | 0.01% | +175.0% |
| Q3 2019 | $627,000 | -28.1% | 188,188 | +6.8% | 0.00% | -33.3% |
| Q2 2019 | $872,000 | -23.6% | 176,138 | -4.4% | 0.01% | -25.0% |
| Q1 2019 | $1,142,000 | +101.4% | 184,238 | +9.5% | 0.01% | +100.0% |
| Q4 2018 | $567,000 | -32.7% | 168,310 | +29.9% | 0.00% | -20.0% |
| Q3 2018 | $842,000 | +45.4% | 129,530 | +71.4% | 0.01% | +66.7% |
| Q2 2018 | $579,000 | – | 75,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |